Lynda Letzig

1.5k total citations
24 papers, 916 citations indexed

About

Lynda Letzig is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Lynda Letzig has authored 24 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 9 papers in Oncology and 7 papers in Hepatology. Recurrent topics in Lynda Letzig's work include Drug-Induced Hepatotoxicity and Protection (16 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Lynda Letzig is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (16 papers), Drug Transport and Resistance Mechanisms (9 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Lynda Letzig collaborates with scholars based in United States, Spain and Czechia. Lynda Letzig's co-authors include Laura P. James, Jack Hinson, Dean W. Roberts, Pippa Simpson, Henry C. Farrar, Michael Gill, William M. Lee, Gregory L. Kearns, J. Gary Wheeler and Gregory L. Kearns and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Lynda Letzig

24 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynda Letzig United States 18 497 233 164 157 152 24 916
J G Kenna United Kingdom 19 605 1.2× 179 0.8× 215 1.3× 156 1.0× 163 1.1× 26 1.3k
Jephte Y. Akakpo United States 16 614 1.2× 294 1.3× 206 1.3× 216 1.4× 150 1.0× 31 882
Yasuhiro Masubuchi Japan 16 598 1.2× 221 0.9× 153 0.9× 115 0.7× 242 1.6× 29 902
Steven I. Shedlofsky United States 21 373 0.8× 168 0.7× 354 2.2× 326 2.1× 226 1.5× 35 1.4k
Tamara R. Knight United States 10 701 1.4× 390 1.7× 301 1.8× 192 1.2× 213 1.4× 10 1.1k
P Lettéron France 20 520 1.0× 133 0.6× 419 2.6× 345 2.2× 217 1.4× 30 1.4k
Camilla Stephens Spain 19 1.0k 2.1× 302 1.3× 173 1.1× 382 2.4× 324 2.1× 44 1.5k
Liyun Yuan United States 10 346 0.7× 188 0.8× 296 1.8× 271 1.7× 135 0.9× 21 914
Inmaculada Medina‐Cáliz Spain 17 617 1.2× 231 1.0× 90 0.5× 280 1.8× 157 1.0× 41 986
Mary K. Bruno United States 9 585 1.2× 186 0.8× 135 0.8× 98 0.6× 212 1.4× 12 743

Countries citing papers authored by Lynda Letzig

Since Specialization
Citations

This map shows the geographic impact of Lynda Letzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Letzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Letzig more than expected).

Fields of papers citing papers by Lynda Letzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynda Letzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Letzig. The network helps show where Lynda Letzig may publish in the future.

Co-authorship network of co-authors of Lynda Letzig

This figure shows the co-authorship network connecting the top 25 collaborators of Lynda Letzig. A scholar is included among the top collaborators of Lynda Letzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynda Letzig. Lynda Letzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gill, Pritmohinder S., Sudeepa Bhattacharyya, Sandra McCullough, et al.. (2017). MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity. Scientific Reports. 7(1). 12331–12331. 46 indexed citations
2.
Roberts, Dean W., William M. Lee, Jack Hinson, et al.. (2016). An Immunoassay to Rapidly Measure Acetaminophen Protein Adducts Accurately Identifies Patients With Acute Liver Injury or Failure. Clinical Gastroenterology and Hepatology. 15(4). 555–562.e3. 51 indexed citations
3.
Bhattacharyya, Sudeepa, Lisa Pence, Ke Yan, et al.. (2016). Targeted metabolomic profiling indicates structure-based perturbations in serum phospholipids in children with acetaminophen overdose. Toxicology Reports. 3. 747–755. 8 indexed citations
4.
Banerjee, Sudeep, Stepan B. Melnyk, Kimberly J. Krager, et al.. (2015). The neuronal nitric oxide synthase inhibitor NANT blocks acetaminophen toxicity and protein nitration in freshly isolated hepatocytes. Free Radical Biology and Medicine. 89. 750–757. 36 indexed citations
5.
Hartman, Jessica H., Lynda Letzig, Dean W. Roberts, et al.. (2015). Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures. Biochemical Pharmacology. 97(3). 341–349. 12 indexed citations
6.
James, Laura P., Ke Yan, Lisa Pence, et al.. (2015). Comparison of Bile Acids and Acetaminophen Protein Adducts in Children and Adolescents with Acetaminophen Toxicity. PLoS ONE. 10(7). e0131010–e0131010. 21 indexed citations
7.
Miyakawa, Kazuhisa, Lynda Letzig, Andreas F. Lehner, et al.. (2015). A Cytochrome P450–Independent Mechanism of Acetaminophen-Induced Injury in Cultured Mouse Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 354(2). 230–237. 20 indexed citations
8.
Mobasher, Maysa A., Juan de Toro‐Martín, Águeda González‐Rodríguez, et al.. (2014). Essential Role of Protein-tyrosine Phosphatase 1B in the Modulation of Insulin Signaling by Acetaminophen in Hepatocytes. Journal of Biological Chemistry. 289(42). 29406–29419. 17 indexed citations
9.
Mobasher, Maysa A., Águeda González‐Rodríguez, Beatriz Santamaría, et al.. (2013). Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity. Cell Death and Disease. 4(5). e626–e626. 76 indexed citations
10.
James, Laura P., Angela L. Chiew, Susan M. Abdel‐Rahman, et al.. (2012). Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations. European Journal of Clinical Pharmacology. 69(4). 851–857. 40 indexed citations
11.
McCullough, Sandra, Leah Hennings, Lynda Letzig, et al.. (2011). Acetaminophen hepatotoxicity and HIF-1α induction in acetaminophen toxicity in mice occurs without hypoxia. Toxicology and Applied Pharmacology. 252(3). 211–220. 23 indexed citations
12.
Hennings, Leah, Tonya Rafferty, Lynda Letzig, et al.. (2011). Acetaminophen-Induced Hepatotoxicity and Protein Nitration in Neuronal Nitric-Oxide Synthase Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 340(1). 134–142. 54 indexed citations
13.
Abdel‐Rahman, Susan M., Aliza Brown, Sandra McCullough, et al.. (2010). Indocyanine green clearance varies as a function of N-acetylcysteine treatment in a murine model of acetaminophen toxicity. Chemico-Biological Interactions. 189(3). 222–229. 13 indexed citations
14.
James, Laura P., Lynda Letzig, Pippa Simpson, et al.. (2009). Pharmacokinetics of Acetaminophen-Protein Adducts in Adults with Acetaminophen Overdose and Acute Liver Failure. Drug Metabolism and Disposition. 37(8). 1779–1784. 139 indexed citations
15.
Letzig, Lynda, et al.. (2008). Acetaminophen-Associated Hepatic Injury: Evaluation of Acetaminophen Protein Adducts in Children and Adolescents With Acetaminophen Overdose. Clinical Pharmacology & Therapeutics. 84(6). 684–690. 52 indexed citations
16.
Farrar, Henry C., Lynda Letzig, & Michael Gill. (2002). Validation of a liquid chromatographic method for the determination of ibuprofen in human plasma. Journal of Chromatography B. 780(2). 341–348. 64 indexed citations
17.
Sudakin, Daniel L., et al.. (2000). Intermediate Syndrome After Malathion Ingestion Despite Continuous Infusion of Pralidoxime. Journal of Toxicology Clinical Toxicology. 38(1). 47–50. 40 indexed citations
18.
Marshall, James D., Thomas G. Wells, Lynda Letzig, & Gregory L. Kearns. (1998). Pharmacokinetics and Pharmacodynamics of Bumetanide in Critically Ill Pediatric Patients. The Journal of Clinical Pharmacology. 38(11). 994–1002. 14 indexed citations
19.
James, Laura P., James D. Marshall, Mark J. Heulitt, et al.. (1996). Pharmacokinetics and Pharmacodynamics of Famotidine in Children. The Journal of Clinical Pharmacology. 36(1). 48–54. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J G Kenna Breakdown of academic impact, for papers by Jephte Y. Akakpo Breakdown of academic impact, for papers by Yasuhiro Masubuchi Breakdown of academic impact, for papers by Steven I. Shedlofsky Breakdown of academic impact, for papers by Tamara R. Knight Breakdown of academic impact, for papers by P Lettéron Breakdown of academic impact, for papers by Camilla Stephens Breakdown of academic impact, for papers by Liyun Yuan Breakdown of academic impact, for papers by Inmaculada Medina‐Cáliz Breakdown of academic impact, for papers by Mary K. Bruno
Rankless by CCL
2026